Higene Biopharmaceutical Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
4
Higene Biopharmaceutical General Information
Description
Developer of marine biomedicine. The company focuses on the development and utilization of "blue drug library", it has taken the lead in screening a batch of "semi-mature" marine innovative drugs with clear efficacy, clear intellectual property rights, and reliable safety assessment data, helping to realize the aggregation development and cascade output of marine biomedicine.
Contact Information
Corporate Office
- Building C, No. 23
- Hong Kong East Road, Laoshan District
- Qingdao, Shandong
- China
Corporate Office
- Building C, No. 23
- Hong Kong East Road, Laoshan District
- Qingdao, Shandong
- China
Higene Biopharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 11-Mar-2022 | Completed | Startup | |||
| 1. Joint Venture | 25-Jul-2019 | Completed | Startup |
Higene Biopharmaceutical Patents
Higene Biopharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240327418-A1 | Multi-target inhibitor targeting hdac and nad synthesis and use of multi-target inhibitor | Pending | 04-Aug-2021 | ||
| WO-2023011416-A1 | Multi-target inhibitor targeting hdac and nad synthesis and use of multi-target inhibitor | Inactive | 04-Aug-2021 | ||
| JP-2024528251-A | Multi-targeted inhibitors targeting hdac and nad synthesis and their uses | Pending | 04-Aug-2021 | A61K31/343 |
Higene Biopharmaceutical Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Qingdao Jufeng Technology Venture Investment | Venture Capital | Minority | ||
| Rongshuhai Private Equity Fund Management (Zhuhai) | Venture Capital | Minority | ||
| Qingdao Huanghai Pharmaceutical | Corporation | Minority | ||
| Qingdao Marine Biomedical Research Institute | Venture Capital | Minority |
Higene Biopharmaceutical FAQs
-
When was Higene Biopharmaceutical founded?
Higene Biopharmaceutical was founded in 2019.
-
Where is Higene Biopharmaceutical headquartered?
Higene Biopharmaceutical is headquartered in Qingdao, China.
-
What industry is Higene Biopharmaceutical in?
Higene Biopharmaceutical’s primary industry is Drug Discovery.
-
Is Higene Biopharmaceutical a private or public company?
Higene Biopharmaceutical is a Private company.
-
What is Higene Biopharmaceutical’s current revenue?
The current revenue for Higene Biopharmaceutical is .
-
Who are Higene Biopharmaceutical’s investors?
Qingdao Jufeng Technology Venture Investment, Rongshuhai Private Equity Fund Management (Zhuhai), Qingdao Huanghai Pharmaceutical, and Qingdao Marine Biomedical Research Institute have invested in Higene Biopharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process